Quadria Capital
Quadria hits $500m first close on third healthcare fund
Singapore-based healthcare specialist Quadria Capital has reached a first close of USD 500m on its third flagship fund. The target is USD 800m.
India healthcare: New momentum, new directions
Private equity has become comfortable with niche segments and regional sub-markets in Indian healthcare services. Technology-based business models are next
Singapore's Quadria secures $200m 'social' credit facility
Singapore-based healthcare specialist Quadria Capital has secured a revolving credit facility of up to USD 200m for investments deemed “social projects.”
Quadria to invest $155m in India eye hospital
Quadria Capital has invested USD 155m in Maxivision Eye Hospital, a chain of 42 eye hospitals and vision clinics across five states in southern and western India.
Quadria to exit Vietnam's FV Hospital via $381m trade sale
Quadria Capital is set to exit Vietnam’s FV Hospital after a strategic buyer agreed to a USD 381.4m acquisition touted as the largest ever healthcare transaction in Vietnam.
Proparco makes $35m LP commitment to Quadria healthcare fund – update
French development finance institution (DFI) Proparco has made a USD 35m fund commitment to Singapore’s Quadria Capital, a healthcare-focused GP active across South and Southeast Asia.
South by Southeast: Asia’s next growth engine?
Grouping together markets based on growth and scale is a problematic with South Asia and Southeast Asia as it was with the BRIC economies. But to some extent, investors are buying into the story
Quadria acquires Malaysia’s Straits Orthopaedics
Singapore-headquartered healthcare specialist Quadria Capital has acquired a majority stake in Malaysian contract devices manufacturer Straits Orthopaedics at an enterprise value of USD 240m.
India-ASEAN GPs rethink Asia growth – AVCJ Forum
Developing Asia is set for a new chapter of greater opportunities and challenges in the wake of the pandemic-related investment boom, the AVCJ Southeast Asia Forum heard.
ADB backs Quadria's third health fund
Asian Development Bank (ADB) has committed USD 25m to the third fund from Singapore-based Quadria Capital, a healthcare-focused private equity firm.
Energy transition case study: Hermina and AIG
Healthcare is not a particularly energy-intensive industry, but specialists such as Quadria Capital are tightening up operations where possible at hospitals
Quadria plans full exit through Concord Biotech's India IPO
Singapore-based healthcare specialist Quadria Capital is set for a full exit from pharmaceuticals industry supplier Concord Biotech via an India IPO.
Quadria eyes $1b for Fund III, emphasizes health-tech
South and Southeast Asia healthcare specialist Quadria Capital is broadening its scope to include areas such as healthcare technology and digital health insurance for Fund III, which is expected to be up to USD 1bn in size.
HealthQuad raises $162m for India healthcare VC fund
HealthQuad, an India-focused healthcare VC investor backed by Quadria Capital, has closed its second fund on USD 162m, more than twice the original target.
Leveraged finance: ESG sells
Private equity firms in Asia are increasingly willing to consider sustainability-linked credit facilities, and banks are generally happy to provide them. Speed is currently delaying standardisation
Deal focus: Quadria goes shopping in Vietnam
Singapore’s healthcare-focused Quadria Capital has made its most overtly consumer retail-oriented investment with Vietnam’s Con Cung. But the endgame is considered squarely on-strategy
India's MediBuddy gets $125m Series C
Quadria Capital and Lightrock India have led a USD 125m Series C round for Indian healthcare platform MediBuddy.
Quadria backs Vietnam mother-and-baby chain
Singapore-based healthcare specialist Quadria Capital has invested USD 90m in Con Cung, Vietnam’s largest mother-and-baby retailer.
2022 preview: Healthcare
Healthcare’s high-cost, rapidly digitizing profile will persist regardless of how COVID-19 plays out in the coming years. China appears set for consolidation, including in biotech
Quadria backs India drug maker Encube Ethicals
A consortium led by healthcare-focused Quadria Capital has invested in Indian topical drugs maker Encube Ethicals, facilitating an exit for Multiples Alternate Asset Management.
Vietnam healthcare: Early days
Hospitals attract most of the capital and interest aimed at Vietnam healthcare. Macro tailwinds are benefiting other parts of the services ecosystem as well, but GPs don’t want to jump too early